BioCryst Pharmaceuticals
BCRX
#5122
Rank
ยฃ1.19 B
Marketcap
ยฃ4.81
Share price
-1.35%
Change (1 day)
-25.19%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ0.32 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are ยฃ0.32 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ0.39 B-3.69%
2023-12-31ยฃ0.40 B-10.74%
2022-12-31ยฃ0.45 B4.34%
2021-12-31ยฃ0.43 B77.44%
2020-12-31ยฃ0.24 B83.71%
2019-12-31ยฃ0.13 B15.55%
2018-12-31ยฃ0.11 B-12.29%
2017-12-31ยฃ0.13 B81.14%
2016-12-31ยฃ72.81 M-11.81%
2015-12-31ยฃ82.56 M-6.08%
2014-12-31ยฃ87.91 M196.76%
2013-12-31ยฃ29.62 M-16.64%
2012-12-31ยฃ35.53 M-32.81%
2011-12-31ยฃ52.89 M-25.4%
2010-12-31ยฃ70.89 M-19.31%
2009-12-31ยฃ87.86 M52.06%
2008-12-31ยฃ57.78 M-19.56%
2007-12-31ยฃ71.83 M105.47%
2006-12-31ยฃ34.96 M-39.25%
2005-12-31ยฃ57.55 M240.3%
2004-12-31ยฃ16.91 M0.52%
2003-12-31ยฃ16.82 M-34.68%
2002-12-31ยฃ25.75 M-36.8%
2001-12-31ยฃ40.75 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
ยฃ42.77 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ60.25 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
ยฃ2.55 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ2.13 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.86 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.47 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
ยฃ6.1 M-98.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
ยฃ20.57 M-93.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ1.06 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA